In 337 children aged 9–10 randomised to mixed nonavalent/bivalent or two-dose nonavalent HPV schedules, HPV16/18 antibodies persisted in 100% at 36 months; HPV16/18 GMCs were higher with mixed schedules. Other types: 94–100% mixed vs 100% homologous.
RCTn = 337
Ionescu et al. Follow up immunogenicity of a mixed vaccination schedule with one dose of nonavalent and one dose of bivalent HPV vaccines 36 months post-vaccination among boys and girls